HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,005,538 | +43.4% | 78,404 | +35.0% | 0.00% | +50.0% |
| Q2 2023 | $2,095,363 | -45.4% | 58,058 | -42.3% | 0.00% | -60.0% |
| Q1 2023 | $3,837,705 | -19.8% | 100,564 | +19.5% | 0.01% | -16.7% |
| Q4 2022 | $4,786,997 | +46.0% | 84,122 | +1.5% | 0.01% | +20.0% |
| Q3 2022 | $3,279,000 | +46.8% | 82,904 | +63.2% | 0.01% | +66.7% |
| Q2 2022 | $2,234,000 | -3.2% | 50,786 | -12.2% | 0.00% | 0.0% |
| Q1 2022 | $2,308,000 | -9.0% | 57,838 | -8.0% | 0.00% | +50.0% |
| Q4 2021 | $2,536,000 | +34.0% | 62,840 | +35.1% | 0.00% | 0.0% |
| Q3 2021 | $1,892,000 | +280.7% | 46,524 | +148.4% | 0.00% | +100.0% |
| Q3 2020 | $497,000 | +170.1% | 18,732 | +80.8% | 0.00% | – |
| Q1 2020 | $184,000 | -21.4% | 10,362 | -20.9% | 0.00% | – |
| Q4 2019 | $234,000 | -59.6% | 13,107 | -64.9% | 0.00% | -100.0% |
| Q3 2019 | $579,000 | +116.9% | 37,342 | +125.0% | 0.00% | – |
| Q1 2019 | $267,000 | +70.1% | 16,597 | +54.6% | 0.00% | – |
| Q4 2018 | $157,000 | -15.6% | 10,738 | -42.8% | 0.00% | – |
| Q4 2016 | $186,000 | +64.6% | 18,782 | +47.5% | 0.00% | -100.0% |
| Q2 2012 | $113,000 | – | 12,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |